Basic Medical College, Inner Mongolia Medical University, Hohhot, People's Republic of China; Beijing Institute of Radiation Medicine, Beijing, People's Republic of China.
Department of General Surgery, Chinese PLA General Hospital, Beijing, People's Republic of China.
Biochem Biophys Res Commun. 2019 Aug 27;516(3):1013-1018. doi: 10.1016/j.bbrc.2016.03.069. Epub 2016 Mar 18.
Aberrant expression of ubiquitin Protein ligase E3C (UBE3C) has been documented in breast cancer (BC). MicroRNAs (miRNAs) were shown to play an important role in the regulation of tumor properties in BC. However, whether miRNAs contributes to UBE3C expression in BC cells remains poorly understood. In this study, we report that UBE3C was a direct target of miR-30a-5p. Expression of miR-30a-5p in BC cells reduced UBE3C expression. MCF-7 and MDA-MB-453 cells were transfected miR-30a-5p-overexpression, and found that cell proliferation and migration were inhibited. In contrast, when miR-30a-5p inhibitor were transfected into MCF-7 and MDA-MB-453 cells, cell proliferation and migration were promoted. We study demonstrated that upregulation of miR-30a-5p was significantly suppressed levels of cyclin B1, cyclin D1 and c-myc. Moreover, Correlation analysis indicated that expression of miR-30a-5p was highly negatively correlated with UBE3C, which was upregulated in BC specimens. These data highlight the important role of miR-30a-5p/UBE3C axis in BC development and progression. Therefore, miR-30a-5p activation or UBE3C inhibition may be provide a novel strategy for the treatment of BC.
泛素蛋白连接酶 E3C(UBE3C)的异常表达已在乳腺癌(BC)中得到证实。microRNAs(miRNAs)被证明在调节 BC 中的肿瘤特性方面发挥着重要作用。然而,miRNAs 是否有助于 BC 细胞中 UBE3C 的表达仍知之甚少。在这项研究中,我们报告 UBE3C 是 miR-30a-5p 的直接靶标。BC 细胞中 miR-30a-5p 的表达降低了 UBE3C 的表达。MCF-7 和 MDA-MB-453 细胞转染 miR-30a-5p 过表达,发现细胞增殖和迁移受到抑制。相反,当 miR-30a-5p 抑制剂转染 MCF-7 和 MDA-MB-453 细胞时,细胞增殖和迁移得到促进。我们的研究表明,miR-30a-5p 的上调显著抑制了细胞周期蛋白 B1、细胞周期蛋白 D1 和 c-myc 的水平。此外,相关性分析表明,miR-30a-5p 的表达与 UBE3C 呈高度负相关,UBE3C 在 BC 标本中上调。这些数据突出了 miR-30a-5p/UBE3C 轴在 BC 发展和进展中的重要作用。因此,miR-30a-5p 的激活或 UBE3C 的抑制可能为 BC 的治疗提供新的策略。